National Framework for Personal Protective Equipment Conformity Assessment-Infrastructure, 1260 [2018-00252]
Download as PDF
<![CDATA[
1260
Federal Register / Vol. 83, No. 7 / Wednesday, January 10, 2018 / Notices
The decision to impose this freeze is
procedural in nature, and therefore is
not subject to the notice and comment
and effective date requirements of the
Administrative Procedure Act, 5 U.S.C.
553(b)(A), (d). Moreover, the Media
Bureau finds that there is good cause for
not delaying the effect of these
procedures until 30 days after
publication in the Federal Register.
Such a delay would be impractical,
unnecessary, and contrary to the public
interest because it would undercut the
purposes of the freeze.
This action is taken by the Chief,
Media Bureau pursuant to authority
delegated by 47 CFR 0.283 of the
Commission’s rules.
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
Food and Drug Administration
[CDC–2013–0015; Docket Number NIOSH
237–A]
Agency Information Collection
Activities; Submission for Office of
Management and Budget Review;
Guidance for Industry: Cooperative
Manufacturing Arrangements for
Licensed Biologics
Federal Communications Commission.
Barbara Kreisman,
Chief, Video Division, Media Bureau.
ACTION:
National Framework for Personal
Protective Equipment Conformity
Assessment—Infrastructure
National Institute for
Occupational Safety and Health
(NIOSH) of the Centers for Disease
Control and Prevention (CDC),
Department of Health and Human
Services (HHS).
AGENCY:
Notice of availability.
NIOSH announces the
availability of the following publication:
National Framework for Personal
Protective Equipment Conformity
Assessment—Infrastructure.
SUMMARY:
[FR Doc. 2018–00286 Filed 1–9–18; 8:45 am]
BILLING CODE 6712–01–P
The technical report was
published on November 17, 2017.
DATES:
FEDERAL MARITIME COMMISSION
The Commission hereby gives notice
of the filing of the following agreement
under the Shipping Act of 1984.
Interested parties may submit comments
on the agreement to the Secretary,
Federal Maritime Commission,
Washington, DC 20573, within twelve
days of the date this notice appears in
the Federal Register. A copy of the
agreement is available through the
Commission’s website (www.fmc.gov) or
by contacting the Office of Agreements
at (202)-523–5793 or tradeanalysis@
fmc.gov.
Agreement No.: 201200–001.
Title: Houston Marine Terminal
Operators/Freight Handlers Agreement.
Parties: Ceres Gulf Inc.; Cooper/Ports
America LLC; and SSA Gulf, Inc.
Filing Party: Shareen Larmond; West
Gulf Maritime Association; 1717
Turning Basin Drive, Suite 200;
Houston, Texas 77029.
Synopsis: The amendment updates
the membership of the Agreement and
makes other administrative changes.
daltland on DSKBBV9HB2PROD with NOTICES
This document may be
obtained at the following link: https://
www.cdc.gov/niosh/docs/2018-102/
default.html.
ADDRESSES:
Notice of Agreement Filed
FOR FURTHER INFORMATION CONTACT:
Maryann M. D’Alessandro, NIOSH,
National Personal Protective
Technology Laboratory, 626 Cochrans
Mill Road, Building 20, Pittsburgh, PA
15236, email address: bpj5@cdc.gov,
(412) 386–6111 (not a toll free number).
In May
2011, NIOSH published a notice in the
Federal Register [76 FR 28791]
requesting comments on the
recommendations issued by the Institute
of Medicine in a report they
electronically published in November
2010, titled, ‘‘Certifying Personal
Protective Technologies.’’ In August
2013, NIOSH published a notice in the
Federal Register [78 FR 49524]
requesting comments on the draft
NIOSH response to the Institute of
Medicine recommendations, and
announcing a public meeting which was
held on September 17, 2013. In response
to a request, NIOSH extended the public
comment period to December 2, 2013.
All comments received were reviewed
and addressed where appropriate.
SUPPLEMENTARY INFORMATION:
By Order of the Federal Maritime
Commission.
Dated: January 5, 2018.
Rachel E. Dickon,
Assistant Secretary.
John Howard,
Director, National Institute for Occupational
Safety and Health, Centers for Disease Control
and Prevention.
[FR Doc. 2018–00289 Filed 1–9–18; 8:45 am]
[FR Doc. 2018–00252 Filed 1–9–18; 8:45 am]
BILLING CODE 6731–AA–P
BILLING CODE 4163–19–P
VerDate Sep<11>2014
18:23 Jan 09, 2018
Jkt 244001
PO 00000
Frm 00028
Fmt 4703
Sfmt 4703
[Docket No. FDA–2011–N–0085]
AGENCY:
Food and Drug Administration,
HHS.
ACTION:
Notice.
The Food and Drug
Administration (FDA, we, or Agency) is
announcing that a proposed collection
of information has been submitted to the
Office of Management and Budget
(OMB) for review and clearance under
the Paperwork Reduction Act of 1995.
DATES: Fax written comments on the
collection of information by February 9,
2018.
ADDRESSES: To ensure that comments on
the information collection are received,
OMB recommends that written
comments be faxed to the Office of
Information and Regulatory Affairs,
OMB, Attn: FDA Desk Officer, Fax: 202–
395–7285, or emailed to oira_
submission@omb.eop.gov. All
comments should be identified with the
OMB control number 0910–0629. Also
include the FDA docket number found
in brackets in the heading of this
document.
SUMMARY:
Ila
S. Mizrachi, Office of Operations, Food
and Drug Administration, Three White
Flint North, 10A–12M, 11601
Landsdown St., North Bethesda, MD
20852, 301–796–7726, PRAStaff@
fda.hhs.gov.
FOR FURTHER INFORMATION CONTACT:
In
compliance with 44 U.S.C. 3507, FDA
has submitted the following proposed
collection of information to OMB for
review and clearance.
SUPPLEMENTARY INFORMATION:
Guidance for Industry: Cooperative
Manufacturing Arrangements for
Licensed Biologics
OMB Control Number 0910–0629—
Extension
This information collection supports
the Agency guidance document entitled,
‘‘Guidance for Industry: Cooperative
Manufacturing for Licensed Biologics’’
(available at: https://www.fda.gov/
downloads/BiologicsBloodVaccines/
GuidanceComplianceRegulatory
Information/Guidances/General/
ucm069908.pdf). The guidance
E:\FR\FM\10JAN1.SGM
10JAN1
]]>Agencies
[Federal Register Volume 83, Number 7 (Wednesday, January 10, 2018)]
[Notices]
[Page 1260]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2018-00252]
=======================================================================
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention
[CDC-2013-0015; Docket Number NIOSH 237-A]
National Framework for Personal Protective Equipment Conformity
Assessment--Infrastructure
AGENCY: National Institute for Occupational Safety and Health (NIOSH)
of the Centers for Disease Control and Prevention (CDC), Department of
Health and Human Services (HHS).
ACTION: Notice of availability.
-----------------------------------------------------------------------
SUMMARY: NIOSH announces the availability of the following publication:
National Framework for Personal Protective Equipment Conformity
Assessment--Infrastructure.
DATES: The technical report was published on November 17, 2017.
ADDRESSES: This document may be obtained at the following link: https://www.cdc.gov/niosh/docs/2018-102/default.html.
FOR FURTHER INFORMATION CONTACT: Maryann M. D'Alessandro, NIOSH,
National Personal Protective Technology Laboratory, 626 Cochrans Mill
Road, Building 20, Pittsburgh, PA 15236, email address: [email protected],
(412) 386-6111 (not a toll free number).
SUPPLEMENTARY INFORMATION: In May 2011, NIOSH published a notice in the
Federal Register [76 FR 28791] requesting comments on the
recommendations issued by the Institute of Medicine in a report they
electronically published in November 2010, titled, ``Certifying
Personal Protective Technologies.'' In August 2013, NIOSH published a
notice in the Federal Register [78 FR 49524] requesting comments on the
draft NIOSH response to the Institute of Medicine recommendations, and
announcing a public meeting which was held on September 17, 2013. In
response to a request, NIOSH extended the public comment period to
December 2, 2013. All comments received were reviewed and addressed
where appropriate.
John Howard,
Director, National Institute for Occupational Safety and Health,
Centers for Disease Control and Prevention.
[FR Doc. 2018-00252 Filed 1-9-18; 8:45 am]
BILLING CODE 4163-19-P
